The investigational compound savolitinib appears to have antitumor activity in patients with c-MET-driven papillary renal cell carcinoma, according to the results of a phase II study released at the 2017 Genitourinary Cancers Symposium in Orlando, FL. Researchers suggest that the
Read more ...
The post Medical News Today: Investigational drug shows promise for hard-to-treat renal cancer appeared first on Biggies Boxers.
source
http://www.biggiesboxers.com/medical-news-today-investigational-drug-shows-promise-for-hard-to-treat-renal-cancer/
No comments:
Post a Comment